These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 3313837

  • 1. Two patterns of sensitization demonstrated by recipients of donor-specific transfusion. Limitations to control by Imuran.
    Colombe BW, Lou CD, Salvatierra O, Garovoy MR.
    Transplantation; 1987 Oct; 44(4):509-15. PubMed ID: 3313837
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Multivariate analysis of risk factors for sensitization and early rejection episodes in a donor-specific transfusion plus azathioprine protocol.
    Burlingham WJ, Stratta RJ, Mason B, Ambrust MJ, Kalayoglu M, Belzer FO, Sollinger HW.
    Transplantation; 1988 Feb; 45(2):342-5. PubMed ID: 3257833
    [Abstract] [Full Text] [Related]

  • 5. Prediction of donor-specific transfusion sensitization. I. A linear logistic model.
    Colombe BW, Juster RP, Salvatierra O, Garovoy MR.
    Transplantation; 1988 Jan; 45(1):101-5. PubMed ID: 3336914
    [Abstract] [Full Text] [Related]

  • 6. "Anti-idiotypic" antibodies to HLA in transiently sensitized DST patients.
    Pohanka E, Manfro RC, Oto C, Colombe BW, Melzer JS, Feduska N, Salvatierra O, Garovoy MR.
    Hum Immunol; 1989 Sep; 26(1):17-26. PubMed ID: 2674072
    [Abstract] [Full Text] [Related]

  • 7. Comparative analysis of the DST and Imuran-plus-DST protocols for live donor renal transplantation.
    Glass NR, Miller DT, Sollinger HW, Belzer FO.
    Transplantation; 1983 Dec; 36(6):636-41. PubMed ID: 6229070
    [Abstract] [Full Text] [Related]

  • 8. Differential effect of pretransplant blood transfusions on immune effector and regulatory compartments in HLA-sensitized and nonsensitized recipients.
    Eikmans M, Waanders MM, Roelen DL, van Miert PP, Anholts JD, de Fijter HW, Brand A, Claas FH.
    Transplantation; 2010 Dec 15; 90(11):1192-9. PubMed ID: 21166103
    [Abstract] [Full Text] [Related]

  • 9. Minimal sensitization and excellent renal allograft outcome following donor-specific blood transfusion with a short course of cyclosporine.
    Cheigh JS, Suthanthiran M, Fotino M, Riggio RR, Schechter N, Stubenbord WT, Stenzel KH, Rubin AL.
    Transplantation; 1991 Feb 15; 51(2):378-81. PubMed ID: 1825244
    [Abstract] [Full Text] [Related]

  • 10. A four-year experience with donor blood transfusion protocols for living-donor renal transplantation.
    Glass NR, Miller DT, Sollinger HW, Belzer FO.
    Transplantation; 1985 Jun 15; 39(6):615-9. PubMed ID: 3890291
    [Abstract] [Full Text] [Related]

  • 11. Beneficial effects of donor-specific transfusions on long-term renal allograft function.
    Anderson CB, Brennan D, Keller C, Goss J, Shenoy S, Burton K, Sicard G, Flye MW.
    Transplant Proc; 1995 Feb 15; 27(1):991-4. PubMed ID: 7879258
    [Abstract] [Full Text] [Related]

  • 12. Risk factors for sensitization by blood transfusions. Comparison of the UW/Madison and UC/San Francisco donor-specific transfusion experience.
    Burlingham WJ, Stratta R, Mason B, Lorentzen D, Feyzi J, Sollinger HW, Belzer FO.
    Transplantation; 1989 Jan 15; 47(1):140-4. PubMed ID: 2911870
    [Abstract] [Full Text] [Related]

  • 13. Antiidiotypic activity and sensitization after donor-specific transfusion (DST) given with and without cyclosporin A (CsA).
    Hillis AN, MacLeod AM, al-Muzairai IA, Innes A, Stewart KN, Power DA, Bone MJ, Sells RA, Catto GR.
    Transplant Proc; 1989 Feb 15; 21(1 Pt 2):1820-1. PubMed ID: 2652591
    [No Abstract] [Full Text] [Related]

  • 14. Update of the University of California at San Francisco experience with donor-specific blood transfusions.
    Salvatierra O, Iwaki Y, Vincenti F, Amend W, Terasaki P, Garovoy M, Duca R, Hopper S, Feduska N.
    Transplant Proc; 1982 Jun 15; 14(2):363-6. PubMed ID: 7051480
    [Abstract] [Full Text] [Related]

  • 15. Induction of antiidiotypic antibodies to donor HLA-A2 following blood transfusions in a highly sensitized HLA-A2+ recipient.
    Burlingham WJ, Pan MH, Mason B, Ceman S, Sollinger HW.
    Transplantation; 1988 Jun 15; 45(6):1066-71. PubMed ID: 3289148
    [Abstract] [Full Text] [Related]

  • 16. Donor-specific transfusions have long-term beneficial effects for human renal allografts.
    Flye MW, Burton K, Mohanakumar T, Brennan D, Keller C, Goss JA, Sicard GA, Anderson CB.
    Transplantation; 1995 Dec 27; 60(12):1395-401. PubMed ID: 8545863
    [Abstract] [Full Text] [Related]

  • 17. Renal transplantation: cyclosporin A and antibody development after donor-specific transfusion.
    al-Muzairai IA, Innes A, Hillis A, Stewart KN, Bone JM, Catto GR, Macleod AM.
    Kidney Int; 1989 Apr 27; 35(4):1057-63. PubMed ID: 2651767
    [Abstract] [Full Text] [Related]

  • 18. Anti-idiotypic antibodies to HLA after donor-specific blood transfusion (DST).
    Pohanka E, Manfro RC, Oto C, Colombe BW, Melzer J, Feduska N, Salvatierra O, Garovoy MR.
    Transplant Proc; 1989 Feb 27; 21(1 Pt 2):1806-9. PubMed ID: 2652590
    [No Abstract] [Full Text] [Related]

  • 19. Effect of cyclosporin, previous third-party transfusion, and pregnancy on antibody development after donor-specific transfusion before renal transplantation.
    Macleod AM, Hillis AN, Mather A, Bone JM, Catto GR.
    Lancet; 1987 Feb 21; 1(8530):416-8. PubMed ID: 2880218
    [Abstract] [Full Text] [Related]

  • 20. Controlled trial of azathioprine and cyclosporin to prevent anti-HLA antibodies due to third-party transfusion.
    Raftery MJ, Lang CJ, O'Shea JM, Varghese Z, Sweny P, Fernando ON, Moorhead JF.
    Nephrol Dial Transplant; 1988 Feb 21; 3(5):671-6. PubMed ID: 3146727
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.